Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma

Epidemiology and Infection

Volumn 117, Issue 3, 1996, Pages 513-517

  Hahn, D L ^a,d   Anttila, T ^e   Saikku, P ^b,c  

^a DEAN MEDICAL CENTER   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d Arcand Park Clinic   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY;

ADULT; AGED; AIRWAY OBSTRUCTION; ANTIBODY TITER; ARTICLE; ASTHMA; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIMARY MEDICAL CARE; RISK; SMOKING;

EID: 0029775277     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268800059197     Document Type: Article

References (21)

1. Cookson JB. Prevalence rates of asthma in developing countries and their comparison with those of Europe and North America. Chest 1987; 91: 97S-103S.
2. Burney P. Epidemiology of asthma. Allergy 1993; 48: 17-23.
3. Hahn DL. Evidence for Chlamydia pneumoniae infection in asthma. In; Allegra L, Blasi F, eds. Chlamydia pneumoniae infection. Milan, Italy: Springer-Verlag, 1995: 65-75.
4. Tomasi TB, Grey HM. Structure and function of immunoglobulin A. Progr Allergy 1972; 16: 81-213.
5. Sarov I, Insler V, Sarov B et al. Specific serum IgA antibodies in the diagnosis of active viral and chlamydial infections. Proceedings of the European Symposium on New Horizons in Microbiology, Facoltà di Medicina e Chirurgia A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy. Amsterdam: Elsevier Science Publishers, 1984; 157-67.
6. Ekman M-R, Grayston JT, Visakorpi R, Kleemola M, Kuo C-c, Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993; 17: 420-5.
7. von Hertzen L, Leinonen M, Surcel HM, Karjalainen J, Saikku P. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae. Clin Diagn Lab Immunol 1995; 2: 454-7.
8. Hahn DL, Saikku P. Serologic evidence for Chlamydia pneumoniae infection in recently symptomatic asthma : a pilot case-control study. Am J Resp Crit Care Med 1995; 151, part 2: A470.
9. American Thoracic Society. Recommended standardized procedures for pulmonary function testing. Am J Resp Dis 1978; 118: 55-77.
10. Wang S-P, Kuo C-C, Grayston JT. Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test. J Clin Microbiol 1979; 10: 259-61.
11. Jauhiainen T, Tuomi T, Leinonen M, Kark JD, Saikku P. Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations for Chlamydia pneumoniae by microimmunofluorescence test. J Clin Microbiol 1994; 32: 839-40.
12. Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130-4.
13. Hahn DL, Dodge R, Golubjatnikov R. Association of Chlamydia pneumonias (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. JAMA 1991; 266: 225-30.
14. Cunningham A, Johnston S, Julious S, Sillis M, Ward ME. The role of Chlamydia pneumoniae and other pathogens in acute episodes of asthma in children. In : Orfila J, et al, eds. Proceedings of the Eighth International Symposium on Human Chlamydial Infections. Chantilly, France, Società Editrice Esculapio, Bologna, Italy, 1994: 480-3.
15. Hukki-Immonen O, Leinenen M, Saikku P. Comparison of local epidemic and TWAR strain in diagnosis of Chlamydia pneumoniae (abstract no. 542). Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, American Society for Microbiology, 1992; 201.
16. Wang S-P, Grayston JT. Population prevalence antibody to Chlamydia pneumoniae, strain TWAR. In: Bowie WR, et al, eds. Chlamydial infections. Cambridge: Cambridge University Press, 1990: 402-5.
17. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Int Med 1992; 116: 273-8.
18. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995; 92: 6911-4.
19. Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arteriosclerosis Thrombosis 1992; 12: 945-7.
20. Karvonen M, Tuomilehto J, Pitkäniemi J, Naukkarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 1994; 23: 1315-21.
21. Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. Scand J Infect Dis 1994; 26: 179-87.